Conflict of interest: none declared.
Cefuroxime-induced pemphigus erythematosus in a young boy
Article first published online: 9 DEC 2008
© 2008 The Author(s). Journal compilation © 2008 British Association of Dermatologists
Clinical and Experimental Dermatology
Volume 34, Issue 6, pages 708–710, August 2009
How to Cite
Baroni, A., Puca, R. V., Aiello, F. S., Palla, M., Faccenda, F., Vozza, G., Sangiuliano, S. and Ruocco, E. (2009), Cefuroxime-induced pemphigus erythematosus in a young boy. Clinical and Experimental Dermatology, 34: 708–710. doi: 10.1111/j.1365-2230.2008.03007.x
- Issue published online: 14 JUL 2009
- Article first published online: 9 DEC 2008
- Accepted for publication 20 June 2008
Pemphigus erythematosus (Senear–Usher syndrome) is a variant of superficial pemphigus with features of both lupus erythematosus and pemphigus. It affects mainly middle-aged adults, and is rarely observed before the age of 20 years. The case of a 14-year-old boy who showed cutaneous lesions suggestive for pemphigus erythematosus is described. Not all laboratory and histopathological investigations confirmed the hypothesis, so a diagnosis of clinical pemphigus erythematosus was made. Systemic steroid therapy was effective in controlling the disease. This case is interesting because of the rare occurrence of pemphigus erythematosus in adolescence and the possibility of another drug being added to the list of pemphigus inducers.